Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
83.67
-3.49 (-4.00%)
At close: Apr 28, 2026, 4:00 PM EDT
84.00
+0.33 (0.39%)
After-hours: Apr 28, 2026, 4:15 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $4.56 billion as of April 28, 2026. Its market cap has increased by 809.03% in one year.
Market Cap
4.56B
Enterprise Value
4.04B
1-Year Change
809.03%
Ranking
Category
Stock Price
$83.67
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $4.56B, an increase of 2,695.02%. That is a compound annual growth rate of 255.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 4.75B | 168.59% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 5.63B |
| Scholar Rock Holding | 5.32B |
| Apellis Pharmaceuticals | 5.24B |
| TG Therapeutics | 5.22B |
| Xenon Pharmaceuticals | 5.18B |
| Corcept Therapeutics | 4.96B |
| CRISPR Therapeutics AG | 4.91B |
| Ligand Pharmaceuticals | 4.85B |